A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...

RFK Jr.’s vaccine panel endorsed Merck’s RSV shot for babies, easing fears that his stance might delay rollout.

The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...

An advisory panel of the U.S. Centers for Disease Control and Prevention on Thursday recommended the use of Merck's ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

The eight new ACIP members met for the first time on June 25 after Kennedy fired all 17 original members of the committee on June 9.

The CDC's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for ...

The newly formed Advisory Committee on Immunization Practices has voted 5-2 to recommend Merck’s respiratory syncytial virus monoclonal antibody drug, clesrovimab, for infants younger than 8 months.

Federal vaccine advisors on Thursday recommended Merck's new RSV antibody shot for infants younger than eight months old in ...

Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...